GlucoTrack, Inc. (GCTK)
NCM · Healthcare · Medical Instruments & Supplies
$0.39
-5.85%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$2.4M
Shares Outstanding
6.3M
Exchange
NCM
Currency
USD
About GlucoTrack, Inc.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -4.8M | -4.3M | -3.5M | -4.2M |
| Net Income | -4.8M | -4.2M | -3.6M | -4.3M |
| Diluted EPS | $-9.62 | $-4.64 | $nan | $-2.65 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -4.4M | -7.1M | -14.5M | -16.1M |
| Net Income | -4.4M | -7.1M | -22.6M | -19.4M |
| Diluted EPS | $-1,740.00 | $-2,050.80 | $-4,106.00 | $-31.22 |